MFDS revises details of approval for ‘Propofol injections’

Published: 2017-06-14 14:21:22

Updated: 2017-06-14 14:21:22

The Ministry of Food and Drug Safety announced revisions in details of approval, such as adding occurrence of acute, congestive heart failure to the usage precautions of ‘propofol injection,’ an antipsychotic.

There are 17 injection products enforced to the revision in the following: △Hana Pharm’s Anepol Inj, △Hana Pharm’s Anepol Inj(for export), △Dongkook Pharmaceutical’s Pofol Inj(Vial), △Do...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.